Abstract
Background The anti-natriuretic properties of growth hormone (GH) are well established. Growth hormone deficiency (GHD) results in salt and water depletion and studies confirm that replacement leads to sodium and vasopressin-mediated water retention in patients with intact posterior pituitary function. Methods We report the case of a 20-year-old male patient with septo-optic dysplasia, fixed cranial diabetes insipidus (DI) and an abnormal thirst threshold. With careful parental support, his sodium levels remained stable for many years on a fixed dose of DDAVP and a supervised fluid intake of 2.5 l/day. Several years after the original diagnosis, he was found to be ACTH deficient and following commencement of hydrocortisone replacement therapy became hypernatraemic. A new sodium homoeostasis was established with a higher dose of DDAVP. Subsequently, he developed symptoms typical of GHD and, after biochemical confirmation, GH replacement was commenced. Results There was an immediate clinical improvement (increased alertness, improved concentration) but severe hypernatraemia developed (peak 169 mmol/l) necessitating revision of his desmopressin and fluid intake regimen. Conclusion Most GHD patients have intact posterior pituitary function. This case report highlights the powerful anti-natriuretic properties of GH. Endocrine physicians should be alert to this in patients with fixed DI and an abnormal thirst threshold.
References
Ludens JH, Bach RR, Williamson HE (1969) Characteristics of the anti-natriuretic action of growth hormone. Proc Soc Exp Biol Med 130:1156–1158
Biglieri EG, Watlington CO, Forsham PH (1961) Sodium retention with human growth hormone and its subfractions. J Clin Endocrinol Metab 21:211–225
Ikkos D, Luft R, Sjogren B (1954) Body water and sodium in patients with acromegaly. J Clin Invest 33:989–994. doi:10.1172/JCI102977
Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G et al (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309–317. doi:10.1210/jc.76.2.309
Moller J, Frandsen F, Fisker S, Jorgensen JOL, Christiansen JS (1996) Decreased plasma and extracellular volume in growth hormone deficient adults and the acute and prolonged effects of GH administration: a controlled experimental study. Clin Endocrinol 44:533–539. doi:10.1046/j.1365-2265.1996.728550.x
Cuneo RC, Salomon F, Wilmshurst P, Byrne C, Wiles CM, Hesp R et al (1991) Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin–aldosterone system. Clin Sci 81:587–592
Herlitz H, Jonsson O, Bengtsson BA (1994) Effect of recombinant human growth hormone on cellular sodium metabolism. Clin Sci 86:233–237
Ho KY, Weissberger AJ (1990) The antinatriuretic action of biosynthetic human growth hormone in man involves activation of the renin–angiotensin system. Metabolism 39:133–137. doi:10.1016/0026-0495(90)90065-K
Moller J, Moller N, Frandsen E, Wolthers T, Jorgensen JO, Christiansen JS (1997) Blockade of the renin–angiotensin–aldosterone system prevents growth hormone-induced fluid retention in humans. Am J Physiol 272:E803–E808
Willnow S, Kiess W, Butenandt O, Dorr HG, Enders A, Straaser-Vogel B et al (1996) Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)-evaluation and follow up of 18 patients. Eur J Pediatr 155:179–184. doi:10.1007/BF01953934
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Misra, S., Johnston, L.B. & Drake, W.M. Severe hypernatraemia associated with growth hormone replacement therapy in a patient with septo-optic dysplasia. Pituitary 13, 186–188 (2010). https://doi.org/10.1007/s11102-008-0144-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-008-0144-0